GEDSF
Price
$24.85
Change
+$1.15 (+4.85%)
Updated
Apr 3 closing price
Capitalization
5.46B
LOVFF
Price
$1.26
Change
+$0.02 (+1.61%)
Updated
Sep 17 closing price
Capitalization
114.83M
Interact to see
Advertisement

GEDSF vs LOVFF

Header iconGEDSF vs LOVFF Comparison
Open Charts GEDSF vs LOVFFBanner chart's image
Gedeon Richter
Price$24.85
Change+$1.15 (+4.85%)
Volume$9.5K
Capitalization5.46B
Cannara Biotech
Price$1.26
Change+$0.02 (+1.61%)
Volume$400
Capitalization114.83M
GEDSF vs LOVFF Comparison Chart in %
Loading...
GEDSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LOVFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GEDSF vs. LOVFF commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEDSF is a Hold and LOVFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (GEDSF: $22.29 vs. LOVFF: $1.26)
Brand notoriety: GEDSF and LOVFF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GEDSF: 100% vs. LOVFF: 6%
Market capitalization -- GEDSF: $5.46B vs. LOVFF: $114.83M
GEDSF [@Pharmaceuticals: Generic] is valued at $5.46B. LOVFF’s [@Pharmaceuticals: Generic] market capitalization is $114.83M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.35B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GEDSF’s FA Score shows that 1 FA rating(s) are green whileLOVFF’s FA Score has 0 green FA rating(s).

  • GEDSF’s FA Score: 1 green, 4 red.
  • LOVFF’s FA Score: 0 green, 5 red.
According to our system of comparison, GEDSF is a better buy in the long-term than LOVFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GEDSF’s TA Score shows that 2 TA indicator(s) are bullish while LOVFF’s TA Score has 4 bullish TA indicator(s).

  • GEDSF’s TA Score: 2 bullish, 0 bearish.
  • LOVFF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GEDSF is a better buy in the short-term than LOVFF.

Price Growth

GEDSF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LOVFF (@Pharmaceuticals: Generic) price change was +0.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +26.39%. For the same industry, the average monthly price growth was +26.40%, and the average quarterly price growth was +60.38%.

Industries' Descriptions

@Pharmaceuticals: Generic (+26.39% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GEDSF($5.46B) has a higher market cap than LOVFF($115M). GEDSF (10.64) and LOVFF (10.19) have similar P/E ratio . LOVFF YTD gains are higher at: 144.509 vs. GEDSF (-4.699). GEDSF has higher annual earnings (EBITDA): 335B vs. LOVFF (27M). GEDSF has more cash in the bank: 150B vs. LOVFF (14.4M). LOVFF has less debt than GEDSF: LOVFF (47.5M) vs GEDSF (21.6B). GEDSF has higher revenues than LOVFF: GEDSF (903B) vs LOVFF (102M).
GEDSFLOVFFGEDSF / LOVFF
Capitalization5.46B115M4,747%
EBITDA335B27M1,240,741%
Gain YTD-4.699144.509-3%
P/E Ratio10.6410.19104%
Revenue903B102M885,294%
Total Cash150B14.4M1,041,667%
Total Debt21.6B47.5M45,474%
FUNDAMENTALS RATINGS
GEDSF vs LOVFF: Fundamental Ratings
GEDSF
LOVFF
OUTLOOK RATING
1..100
5089
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
54
Fair valued
PROFIT vs RISK RATING
1..100
6465
SMR RATING
1..100
4751
PRICE GROWTH RATING
1..100
7639
P/E GROWTH RATING
1..100
8456
SEASONALITY SCORE
1..100
4950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GEDSF's Valuation (2) in the null industry is somewhat better than the same rating for LOVFF (54). This means that GEDSF’s stock grew somewhat faster than LOVFF’s over the last 12 months.

GEDSF's Profit vs Risk Rating (64) in the null industry is in the same range as LOVFF (65). This means that GEDSF’s stock grew similarly to LOVFF’s over the last 12 months.

GEDSF's SMR Rating (47) in the null industry is in the same range as LOVFF (51). This means that GEDSF’s stock grew similarly to LOVFF’s over the last 12 months.

LOVFF's Price Growth Rating (39) in the null industry is somewhat better than the same rating for GEDSF (76). This means that LOVFF’s stock grew somewhat faster than GEDSF’s over the last 12 months.

LOVFF's P/E Growth Rating (56) in the null industry is in the same range as GEDSF (84). This means that LOVFF’s stock grew similarly to GEDSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GEDSFLOVFF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
30%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
26%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
74%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
GEDSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LOVFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCTIX52.89N/A
N/A
Goldman Sachs US Tax-Managed Eq Instl
BUFBX21.49N/A
N/A
Buffalo Flexible Allocation
PDAIX12.81N/A
N/A
PineBridge Dynamic Asset Allc Instl
FFICX66.72-0.30
-0.44%
American Funds Invmt Co of Amer F3
IIGCX16.74-0.09
-0.53%
VanEck International Investors Gold C

GEDSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GEDSF has been loosely correlated with APNHF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GEDSF jumps, then APNHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GEDSF
1D Price
Change %
GEDSF100%
N/A
APNHF - GEDSF
51%
Loosely correlated
N/A
MSTH - GEDSF
22%
Poorly correlated
N/A
UPC - GEDSF
4%
Poorly correlated
+5.33%
KKPCF - GEDSF
3%
Poorly correlated
N/A
CLCFF - GEDSF
3%
Poorly correlated
-2.16%
More

LOVFF and

Correlation & Price change

A.I.dvisor tells us that LOVFF and VPHIF have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LOVFF and VPHIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LOVFF
1D Price
Change %
LOVFF100%
+1.45%
VPHIF - LOVFF
17%
Poorly correlated
N/A
KKPCF - LOVFF
6%
Poorly correlated
N/A
VTRS - LOVFF
3%
Poorly correlated
+0.63%
VEXTF - LOVFF
1%
Poorly correlated
+0.94%
GEDSF - LOVFF
-0%
Poorly correlated
N/A
More